Landis G. Michael, CFO of Polaryx Therapeutics ($PLYX), bought shares once on the open market in the last year for nearly $8,000. His latest purchase occurred on February 18, 2026. This ranks 4,423rd among 4,983 insiders, well below the average $1.5 million purchase across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Polaryx Therapeutics, Inc. | $PLYX | Landis G. Michael | Chief Financial Officer | P | Common Stock | 2867 | $2.79 | 228,225.0000 | 0 | 1.27% | 0.00% |